1. Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer
- Author
-
Jin-Hu Qiang, Xian-Zhen Ding, Shi-Qiang Zhang, and Xiao-Lan Deng
- Subjects
Adult ,Cancer Research ,Prognosis prediction ,cervical cancer ,diagnosis ,Uterine Cervical Neoplasms ,Kaplan-Meier Estimate ,exosomes ,lcsh:RC254-282 ,03 medical and health sciences ,0302 clinical medicine ,Biomarkers, Tumor ,Humans ,Medicine ,Neoplasm Metastasis ,Neoplasm Staging ,030304 developmental biology ,Homeodomain Proteins ,Cervical cancer ,0303 health sciences ,Oncogene ,business.industry ,Cancer ,Middle Aged ,Prognosis ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,Microvesicles ,DLX6-AS1 ,ROC Curve ,Oncology ,Case-Control Studies ,030220 oncology & carcinogenesis ,Cancer research ,biomarker ,Biomarker (medicine) ,Female ,RNA, Long Noncoding ,Original Article ,Neoplasm Grading ,business ,Cell-Free Nucleic Acids - Abstract
Objective: Deregulation of long noncoding RNAs (lncRNAs) is involved in the initiation and progression of cancer. LncRNA DLX6-AS1 is regarded as an oncogene in many cancer types. However, the clinical role of serum exosomal lncRNA DLX6-AS1 in cervical cancer (CC) is poorly known. This study aimed to analyze the diagnostic and prognostic value of serum exosomal lncRNA DLX6-AS1 in CC. Methods: A total of 114 patients with CC, 60 patients with CIN (cervical intraepithelial neoplasia), and 110 healthy women were enrolled in this study. Real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed to measure the serum exosomal lncRNA DLX6-AS1 levels in all participants. Results: Serum exosomal lncRNA DLX6-AS1 level was significantly elevated in CC patients compared with CIN patients and normal controls. In addition, high serum exosomal lncRNA DLX6-AS1 expression was positively associated with lymph node metastasis, differentiation, FIGO stage, and shortened survival. Patients with high serum exosomal lncRNA DLX6-AS1 expression were more prone to have a relapse. Furthermore, univariate and multivariate analyses suggested that serum exosomal lncRNA DLX6-AS1 was a potential prognostic indicator for overall survival of CC patients. Conclusions: These findings demonstrated that serum lncRNA DLX6-AS1 might serve as a promising marker for the diagnosis and prognosis prediction of CC. more...
- Published
- 2021
- Full Text
- View/download PDF